Equitec Proprietary Markets, LLC A Ikido Pharma Inc. Transaction History

Equitec Proprietary Markets, LLC

  • $92.9 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
SELL
$3.07 - $7.21 $18,113 - $42,539
-5,900 Reduced 31.38%
12,900 $42,000
Q3 2022

Oct 11, 2022
SELL
$5.6 - $7.03 $249,071 - $312,673
-44,477 Reduced 70.29%
18,800 $129,000
Q2 2022

Jul 18, 2022
BUY
$4.59 - $7.99 $290,441 - $505,583
63,277 New
63,277 $373,000

Others Institutions Holding AIKI

# of Institutions
16
Shares Held
459K
Call Options Held
0
Put Options Held
0
View Full List

About AIkido Pharma Inc.

AIKI Quotes by TradingView
  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track Equitec Proprietary Markets, LLC Portfolio

Follow Equitec Proprietary Markets, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitec Proprietary Markets, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Equitec Proprietary Markets, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email